1. Alzheimer’s Association 2010 Changing the Trajectory of Alzheimer’s Disease: A National Imperative. http://www.alz.org/trajectory .
2. Daviglus ML, Bell CC, Berrettini W, Bowen PE, Connolly ES, Jr., Cox NJ, Dunbar-Jacob JM, Granieri EC, Hunt G, McGarry K, Patel D, Potosky AL, Sanders-Bush E, Silberberg D, Trevisan M 2010 National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline. NIH Consens State Sci Statements 27:1–30
3. Muldoon MF, Ryan CM, Sheu L, Yao JK, Conklin SM, Manuck SB 2010 Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthood. J Nutr 140:848–853
4. Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PW, Wolf PA 2006 Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol 63:1545–1550
5. Huang TL 2010 Omega-3 fatty acids, cognitive decline, and Alzheimer’s disease: a critical review and evaluation of the literature. J Alzheimers Dis 21:673–690